An open label, single center study to assess the pharmacokinetics, safety and tolerability of multiple administrations of 30 mg PMI-150 (intranasal ketamine) in healthy adult volunteers
Phase of Trial: Phase I
Latest Information Update: 13 Aug 2008
At a glance
- Drugs Ketamine (Primary)
- Indications Acute pain; Cancer pain
- Focus Pharmacokinetics
- Sponsors Javelin Pharmaceuticals
- 13 Aug 2008 Pharmacokinetic data presented at the Department of Defense's 2008 Advanced Technology Applications for Combat Casualty Care (ATACCC) Conference.
- 31 Aug 2007 New trial record.